http://www.unboundmedicine.com/medline/ebm/research/SereventUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19040347/full_citation/Inhaled_corticosteroids_in_COPD:_systemic_effects_of_a_local_therapyAntoniu SA 
Inhaled corticosteroids in COPD: systemic effects of a local therapy? [Journal Article]
Expert Opin Pharmacother 2008 Dec; 9(18):3271-3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19032138/full_citation/Comparison_of_the_clinical_efficacy_and_safety_of_salmeterol/fluticasone_propionate_versus_current_care_in_the_management_of_persistent_asthma_in_Korea_Jung KS, Uh ST, Lee YC, et al. 
Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea. [Journal Article]
Curr Med Res Opin 2008 Dec; 24(12):3571-82.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19032127/full_citation/Cost_effectiveness_analysis_of_budesonide/formoterol_maintenance_and_reliever_therapy_versus_fixed_combination_treatments_for_asthma_in_Finland___Tamminen K, Laine J, Soini E, et al. 
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland *. [Journal Article]
Curr Med Res Opin 2008 Dec; 24(12):3453-61.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19032125/full_citation/Association_between_adherence_with_fixed_dose_combination_fluticasone_propionate/salmeterol_on_asthma_outcomes_and_costs___Delea TE, Stanford RH, Hagiwara M, et al. 
Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs *. [Journal Article]
Curr Med Res Opin 2008 Dec; 24(12):3435-42.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19026757/full_citation/Safety_of_regular_use_of_long_acting_beta_agonists_as_monotherapy_or_added_to_inhaled_corticosteroids_in_asthma__A_systematic_review_Rodrigo GJ, Moral VP, Marcos LG, et al. 
Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. [JOURNAL ARTICLE]
Pulm Pharmacol Ther 2008 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19014847/full_citation/A_retrospective_study_of_the_use_of_fluticasone_propionate/salmeterol_combination_as_initial_asthma_controller_therapy_in_a_commercially_insured_population_Friedman H, Wilcox T, Reardon G, et al. 
A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population. [Journal Article]
Clin Ther 2008 Oct; 30(10):1908-17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19014765/full_citation/Factors_associated_with_asthma_exacerbations_during_a_long_term_clinical_trial_of_controller_medications_in_children_Covar RA, Szefler SJ, Zeiger RS, et al. 
Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. [Journal Article, Research Support, N.I.H., Extramural]
J Allergy Clin Immunol 2008 Oct; 122(4):741-747.e4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19014570/full_citation/Duration_of_salmeterol_induced_bronchodilation_in_mechanically_ventilated_COPD_patients:_a_prospective_clinical_study_Malliotakis P, Linardakis M, Gavriilidis G, et al. 
Duration of salmeterol-induced bronchodilation in mechanically ventilated COPD patients: a prospective clinical study. [JOURNAL ARTICLE]
Crit Care 2008 Nov 14; 12(6):R140.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19011503/full_citation/Arrhythmias_in_patients_with_chronic_obstructive_pulmonary_disease__COPD_:_occurrence_frequency_and_the_effect_of_treatment_with_the_inhaled_long_acting_beta2_agonists_arformoterol_and_salmeterol_Hanrahan JP, Grogan DR, Baumgartner RA, et al. 
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. [Journal Article, Research Support, Non-U.S. Gov't]
Medicine (Baltimore) 2008 Nov; 87(6):319-28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19010983/full_citation/Fluctuation_analysis_of_lung_function_as_a_predictor_of_long_term_response_to_{beta}2_agonists_Thamrin C, Stern G, Strippoli MP, et al. 
Fluctuation analysis of lung function as a predictor of long-term response to {beta}2-agonists. [JOURNAL ARTICLE]
Eur Respir J 2008 Nov 14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles